indirubin has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balvers, RK; Berghauser Pont, LM; Chiocca, EA; Dirven, CM; Kloezeman, JJ; Kremer, A; Lamfers, ML; Lawler, SE; Leenstra, S; Nowicki, MO; van den Bossche, W; van den Hoogen, BG; Wakimoto, H | 1 |
| Abdel-Rasoul, M; Chiocca, EA; Fernandez, SA; Godlewski, J; Kaur, B; Lawler, SE; Liu, F; Nowicki, MO; Press, R; Williams, SP | 1 |
2 other study(ies) available for indirubin and Brain Neoplasms
| Article | Year |
|---|---|
In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluphenazine; Glioblastoma; HCT116 Cells; Humans; Indoles; Neoplastic Stem Cells; Oncolytic Virotherapy; Oncolytic Viruses; Virus Replication | 2015 |
Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioma; Glycogen Synthase Kinase 3; Humans; Indoles; Mice; Neoplasm Invasiveness | 2011 |